Management of facial nerve schwannoma: when is the timing for surgery

Cho, Young Sang; Choi, Ji Eun; Lim, Ji Hyun

doi:10.1007/s00405-021-06765-x

Cited by 12 publications

(7 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…13 Abstention with close supervision is only recommended in case of neuromas with normal facial function or minimal paresis H-B less than III. 14 Radiation is an emerging treatment modality for facial schwannomas. Its aim is to avoid further tumour growth and to preserve residual facial function.…”

Section: Discussionmentioning

confidence: 99%

Management of a facial nerve schwannoma with fractionated stereotactic radiotherapy: a case report

Mousli¹,

Ayadi²,

Yousfi³

et al. 2023

J Radiother Pract

View full text Add to dashboard Cite

Introduction: Neuroma of the facial nerve (NFN) is an extremely rare benign tumour that can involve any segment of the facial nerve. It is revealed by facial weakness with or without hearing loss and has commonly been managed by microsurgery. Our purpose is to systematically review the literature about the role of fractionated stereotactic radiotherapy (FSRT) on the treatment of NFN. Clinical case: We report the case of a 70-year-old-woman who presented progressively worsening facial paralysis associated with mild conductive hearing loss and dizziness. The multimodal magnetic resonance imaging (MRI) was very suggestive of an intrapetrous neuroma, centred on the tract of the VII nerve and the left geniculate ganglion. She was treated by FSRT at the dose of 18 Gy in three fractions on the isodose line 80 %. After 18-month follow-up, she reported a facial weakness improvement. The MRI revealed a stable disease. Conclusion: The clinical presentation of the schwannoma of the facial nerve depends essentially on its location. It is therefore very variable, ranging from an isolated mild hearing loss to a vestibular syndrome with facial paralysis. Through this observation with literature review, we reported a long-term tumour control with improvement of pre-treatment symptomatology with FSRT.

show abstract

Section: Discussionmentioning

confidence: 99%

Management of a facial nerve schwannoma with fractionated stereotactic radiotherapy: a case report

Mousli¹,

Ayadi²,

Yousfi³

et al. 2023

J Radiother Pract

View full text Add to dashboard Cite

show abstract

“…Treatment for facial schwannoma has changed over time, and because it is a rare tumor, there are various debates regarding the treatment options [ 12 ]. Tumors do not often regrow even after subtotal resection, and facial nerve paralysis greatly impairs the quality of life.…”

Section: Discussionmentioning

confidence: 99%

Intratemporal Facial Nerve Schwannomas: A Review of 45 Cases in A Single Center

et al. 2022

View full text Add to dashboard Cite

There are no established indications for facial nerve schwannoma treatment, including surgery, radiation and follow-up observation, and it is difficult to determine treatment policy uniformly. The treatment policy was examined from each treatment course. Data of patients with facial nerve schwannomas at our hospital from 1987 to 2018 were retrospectively examined. Their age, sex, clinical symptoms, tumor localization, treatment policies and outcomes were reviewed. In total, 22 patients underwent surgery and 1 patient underwent radiotherapy; 22 patients were followed up without treatment. After total resection, there were no tumor recurrences, and most patients had grade 3 or 4 postoperative facial paralysis. After subtotal resection, tumor regrowth was observed in four patients and reoperation was required in two patients. Facial nerve function was maintained in four patients and was decreased in two patients. During follow-up, six patients showed tumor growth. Only one patient had worsening facial nerve paralysis; four patients underwent facial nerve decompression owing to facial nerve paralysis during follow-up. If the tumor compresses the brain or it is prone to growth, surgery may be indicated, and when the preoperative facial nerve function is grade ≤3, consideration should be given to preserving facial nerve function and subtotal resection should be indicated. If the preoperative facial nerve function is grade ≥3, total resection with nerve grafting is an option to prevent regrowth. If there is no brain compression or tumor growth, the follow-up is a good indication, and decompression should be considered in facial nerve paralysis cases.

show abstract

“…It should also be noted that a certain percentage of tumors do not grow without intervention. Although several studies have reported treatment timing [8,9 ▪ ], no established standard for treatment selection integrates each perspective.…”

Section: Facial Nerve Schwannomamentioning

confidence: 99%

Facial nerve schwannoma and other benign neoplastic facial nerve lesions

Kitama

Oishi

2023

Current Opinion in Otolaryngology &Amp; Head &Amp; Neck Surgery

View full text Add to dashboard Cite

Purpose of review Several neoplastic lesions may originate from facial nerves, including facial nerve schwannomas. These neoplastic lesions can cause various symptoms, such as facial nerve paralysis, and decrease the quality of life of patients. Therefore, knowledge of how to manage these diseases is important for otologists. However, the incidence of these diseases is extremely low, and universal management methods have not yet been established. This review summarizes recent advances in knowledge regarding these neoplastic lesions, especially facial nerve schwannomas. Recent findings Recent advances and the accumulation of knowledge regarding these benign facial nerve lesions have provided several preferable treatments and management methods, especially for facial nerve schwannomas. However, this still depends on the patient's symptoms and tumor localization. Summary This review presents the optimal treatment protocol and differential diagnosis of benign facial nerve lesions. This may be useful for pretreatment differentiation and treatment decision-making.

show abstract

Management of facial nerve schwannoma: when is the timing for surgery

Cited by 12 publications

References 24 publications

Management of a facial nerve schwannoma with fractionated stereotactic radiotherapy: a case report

Management of a facial nerve schwannoma with fractionated stereotactic radiotherapy: a case report

Intratemporal Facial Nerve Schwannomas: A Review of 45 Cases in A Single Center

Facial nerve schwannoma and other benign neoplastic facial nerve lesions

Contact Info

Product

Resources

About